(Q98776197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

title

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Caitlin Edwards

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Stephanie A Montgomery

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Yixuan Hou

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Lily E Adams

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Matthew D Bryant

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Timothy P Sheahan

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Ralph S. Baric

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

2

Sarah R Leist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

11

Kendra L Gully

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

17

Lisa E Gralinski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

12

Ariane J Brown

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

8

Boyd L Yount

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

15

Ingrid C Choong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

3

Alexandra Schäfer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

5

David R Martinez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

7

Ande West

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

author name string

Emily Huang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

Jeffrey S Glenn

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

language of work or name

English

0 references

publication date

27 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

30 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32854108%20AND%20SRC:MED&resulttype=core&format=json

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

30 August 2020

volume

586

0 references

issue

7830

0 references

page(s)

560-566

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

COVID-19: lambda interferon against viral load and hyperinflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

SARS-like WIV1-CoV poised for human emergence

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Uncovering inherent cellular plasticity of multiciliated ependyma leading to ventricular wall transformation and hydrocephalus.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

New Metrics for Evaluating Viral Respiratory Pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

SARS and MERS: recent insights into emerging coronaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Emerging concepts for the treatment of hepatitis delta

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Structural basis of receptor recognition by SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Inhibition of SARS-CoV-2 by type I and type III interferons

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

IFN-lambda preferably inhibits PEDV infection of porcine intestinal epithelial cells compared with IFN-alpha.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Potently neutralizing and protective human antibodies against SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021

IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2708-8

7 January 2021